Fig. 2: ALPK2 knockdown inhibited bladder cancer development in vitro.
From: ALPK2 acts as tumor promotor in development of bladder cancer through targeting DEPDC1A
A Celigo cell counting assay was employed to show the effects of ALPK2 on cell proliferation of EJ and T24 cells. B Flow cytometry was performed to detect cell apoptosis of EJ and T24 cells with or without ALPK2 knockdown. C Human apoptosis antibody array was utilized to analyze the regulatory ability of ALPK2 on expression of apoptosis-related proteins in T24 cells. D, E The effects of ALPK2 on cell migration ability of EJ and T24 cells were evaluated by wound-healing assay (D) and Transwell assay (E). The representative images were selected from at least three independent experiments. Data were shown as mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001.
